# Virax Biolabs Group Ltd. (VRAX)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $0.18 (+1.07%)

> Virax Biolabs Group Ltd. is a company specializing in the development and distribution of diagnostic testing kits and related products for the detection and management of viral diseases. The primary purpose of Virax Biolabs is to provide healthcare solutions that aid in the early detection of viral pathogens, a crucial step in preventing the spread of infectious diseases and enabling effective medical intervention. Its products are vital across various sectors including healthcare institutions, government health departments, and research organizations. The company's innovations are particularly significant amid global health crises, offering crucial tools for public health surveillance and response. By serving a diverse market, Virax Biolabs plays a key role in supporting public health initiatives and enhancing the capacity of healthcare systems to manage viral threats effectively. The company's operations underscore the importance of advancing medical diagnostics to safeguard community health and well-being.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/VRAX)